Relationship between diabetes and risk of second primary contralateral breast cancer

被引:0
作者
Christopher I. Li
Janet R. Daling
Mei-Tzu C. Tang
Kathleen E. Malone
机构
[1] Fred Hutchinson Cancer Research Center,Division of Public Health Sciences
来源
Breast Cancer Research and Treatment | 2011年 / 125卷
关键词
Breast cancer; Diabetes; Contralateral breast cancer;
D O I
暂无
中图分类号
学科分类号
摘要
Breast cancer survivors have a substantially higher risk of developing a second primary contralateral breast cancer (CBC) compared to the risk of breast cancer among women in the general population. While data regarding the relationship between diabetes and breast cancer incidence are inconsistent, diabetes is more clearly linked to an elevated risk of all-cause mortality among breast cancer survivors. However, no prior studies have assessed its impact on CBC risk. We assessed the relationship between diabetes, and CBC risk in a population-based nested case–control study consisting of women 40–79 years of age diagnosed with a first primary ER-positive invasive breast cancer. It included 322 women who developed a second primary CBC and 616-matched control women diagnosed only with a first breast cancer. We used conditional logistic regression to quantify associations between diabetes and CBC risk. Compared to women without a history of diabetes, diabetics had a 2.2-fold [95% confidence interval (CI) 1.3–3.6] increased risk of CBC. This risk was more pronounced among women diagnosed with their first breast cancer before age 60 years (odds ratio, OR = 11.5, 95% CI 2.4–54.5), compared to those diagnosed at age 60 years or older (OR = 1.5, 95% CI 0.8–2.7, P for interaction = 0.011). Diabetics diagnosed with breast cancer appear to have an elevated risk of CBC. This is the first study to report this relationship, but if confirmed efforts to insure that diabetic breast cancer survivors are carefully screened for second breast cancers may be warranted.
引用
收藏
页码:545 / 551
页数:6
相关论文
共 73 条
  • [1] Barone BB(2008)Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis JAMA 300 2754-2764
  • [2] Yeh HC(2010)Long-term metformin use is associated with decreased risk of breast cancer Diabetes Care 33 1304-1308
  • [3] Snyder CF(1999)Epidemiology of contralateral breast cancer Cancer Epidemiol Biomarkers Prev 8 855-861
  • [4] Peairs KS(1998)Tamoxifen for early breast cancer: an overview of the randomised trials Lancet 351 1451-1467
  • [5] Stein KB(2010)Metformin: a therapeutic opportunity in breast cancer Clin Cancer Res 16 1695-1700
  • [6] Derr RL(2003)Insulin, insulin-like growth factor-I and breast cancer risk in Japanese women Asian Pac J Cancer Prev 4 239-246
  • [7] Wolff AC(2002)Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies J Natl Cancer Inst 94 606-616
  • [8] Brancati FL(2007)Diabetes mellitus and risk of breast cancer: a meta-analysis Int J Cancer 121 856-862
  • [9] Bodmer M(2004)Hyperinsulinaemia and increased risk of breast cancer: findings from the British women’s heart and health study Cancer Causes Control 15 267-275
  • [10] Meier C(2002)Serum insulin and glucose levels and breast cancer incidence: the atherosclerosis risk in communities study Am J Epidemiol 156 349-352